# AI建议在胸片确诊前推迟对患有呼吸窘迫综合征的早产儿使用表面活性剂，忽略了时间关键窗口

- **ID:** `medical/neonatal-respiratory-distress-surfactant-timing`
- **领域:** medical
- **类别:** runtime_error
- **错误码:** `NEO-SURF-002`
- **验证级别:** ai_generated
- **修复率:** 82%

## 根因

早产儿RDS的表面活性剂治疗在出生后前2小时内（早期抢救）最有效；为等待胸片确认而推迟可能错过治疗窗口，增加气胸和支气管肺发育不良风险。

## 解决方案

1. ```
   Apply the 'early rescue' protocol: if FiO2 >0.30 to maintain SpO2 >90% in a preterm infant <32 weeks with clinical RDS, administer surfactant (e.g., poractant alfa 200 mg/kg) via endotracheal tube within 30 minutes of meeting criteria. Do not wait for X-ray.
   ```
2. ```
   Use the 'INSURE' technique (Intubation, Surfactant, Extubation) for infants >28 weeks to minimize ventilator time. Administer surfactant, then extubate to nasal CPAP if stable.
   ```
3. ```
   If X-ray is unavoidable, prioritize clinical scoring (e.g., Silverman-Anderson score >6) as surrogate. Obtain portable chest X-ray without moving infant from radiant warmer, and administer surfactant immediately after film if RDS pattern present.
   ```

## 无效尝试

- **Wait for arterial blood gas results to confirm hypoxia before giving surfactant** — Clinical signs (grunting, retractions, FiO2 >0.3) are sufficient for early rescue; waiting for ABG delays treatment and increases severity. (80% 失败率)
- **Administer surfactant only after a positive 'shake test' on gastric aspirate** — Shake test is obsolete and unreliable; current guidelines recommend clinical assessment and FiO2 threshold for early rescue therapy. (95% 失败率)
- **Use a single dose regardless of response, without reassessment** — Some neonates require multiple doses (up to 3) if initial response is poor; fixed single-dose approach leads to undertreatment. (70% 失败率)